(P19) Single Fraction High Dose Rate Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer: Early Results of a Single Institutional Experience

High dose rate (HDR) brachytherapy as monotherapy has been recently established as a treatment modality for low- and/or intermediate-risk prostate cancer (LIR-PC); however, clinical results of this technique remain limited. Here we describe our institutional HDR monotherapy experience and report early clinical outcomes.

https://www.redjournal.org/article/S0360-3016(18)30406-1/fulltext?rss=yes

Source: International Journal of Radiation Oncology * Biology * Physics - May 3, 2018 Category: Radiology Authors: Justin Barnes, Max Sanders, Prashant Gabani, Anupama Chundury, Jeff Michalski, Hiram Gay Tags: Poster Abstract Source Type: research